MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0033929
North India Pharma Private Limited
North India Pharma Private Limited - chemicals and materials in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.92 Cr
▲ 53% YoY
Net profit · FY 2025
₹5.82 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹9.86 Lakh
EBITDA margin 1.1%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About North India Pharma Private Limited
Data last updated:
North India Pharma Private Limited is a private limited company based in Delhi, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 08 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52100DL2014PTC263184. Its GSTIN is 07AAECN6438N1ZY (Delhi).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Paras Doshi and Mudit Doshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 42 Ground Floor, Vardhman Fashion Mall Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.92 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹5.82 Lakh (net margin 0.7%) and EBITDA of ₹9.86 Lakh (EBITDA margin 1.1%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 1 case is pending.
North India Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0033929). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U52100DL2014PTC263184
Registration Number 263184
Incorporation Date 08 January 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0033929
Recognitions & Rankings of North India Pharma
Contact details
North India Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG – 42 Ground Floor, Vardhman Fashion Mall Pitampura, Delhi, India – 110034
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of North India Pharma Private Limited, buy the company report.
Comprehensive company report
North India Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of North India Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of North India Pharma Private Limited, buy the company report.
Financials of North India Pharma Private Limited
FY 2025 filings availableNorth India Pharma Private Limited reported revenue of ₹8.92 Cr (up 53% YoY) for FY 2025.
Revenue · FY 2025
₹8.92 Cr ▲ 53%
Net profit · FY 2025
₹5.82 Lakh margin 0.7%
EBITDA · FY 2025
₹9.86 Lakh margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 53%
3 years · compounded
▼ 14%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▼ 71%
5 years · compounded
▼ 29%
Revenue rose 53% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of North India Pharma Private Limited, buy the company report.
Board of directors of North India Pharma Private Limited
North India Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mudit Doshi | Additional Director | 30 May 2024 | 2 Years 5 Months | Current |
| Paras Doshi Also directs: North India Phytochemicals LLP, Namo Lifesciences LLP, Dhanvantari Life Sciences Limited and 1 more | Director | 08 Jan 2014 | 12 Years 9 Months | Current |
Peer comparison
North India Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fox Tradelinks Private Limited | ₹8.94 Cr (FY 2025) | -20.0% | Thane, Maharashtra, India | |||
| Million Technocoats Private Limited | ₹8.93 Cr (FY 2025) | 15.0% | Chennai, Tamil Nadu, India | |||
| Empiai Pharmaceuticals Private Limited | ₹8.93 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| I Ox Industries Private Limited | ₹8.92 Cr (FY 2025) | 379.0% | Ludhiana, Punjab, India | |||
| North India Pharma Private Limitedthis company | ₹8.92 Cr (FY 2025) | ₹5.82 Lakh | 0.7% | 53.0% | Delhi, India | |
| Wallgrip India Private Limited | ₹8.91 Cr (FY 2025) | 89.0% | Delhi, India |
To see the full peer comparison of North India Pharma Private Limited, buy the company report.
Auditor
North India Pharma Private Limited is audited by DEVESH PAREKH & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEVESH PAREKH & CO. | FY 2023 | 013338N |
Shareholding
The shareholding of North India Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of North India Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 May 2023 | 100755559 | Hdfc Bank Limited | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
North India Pharma Private Limited has 3 court cases on record: 1 filed by North India Pharma, 2 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
1
Filed against the company
2
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 1 |
| High courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed against the company by M/S Francis Remedies India Private Limited | Pending |
| High Court of Delhi | Court case (RFA(COMM)) | Filed against the company by M/S Deccan Health Care Limited | Disposed |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against M/S. Deccan Health Care Pvt. Ltd. | Disposed |
To see the full case history of North India Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for North India Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
North India Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECN6438N1ZY | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of North India Pharma Private Limited, buy the company report.
Recent activity
North India Pharma Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Shailen Doshi ceased to be Director on 31 May 2024.
AGM
North India Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
North India Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Shailen Doshi ceased to be Director.
Appointed
Mudit Doshi was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Lakh with Charge ID 100755559 was registered on 15 May 2023.
Appointed
Paras Doshi was appointed as Director.
Incorporation
08 Jan 2014
North India Pharma Private Limited was registered on 08 Jan 2014 with Roc Delhi & aged 12 years 9 months as per MCA records.
Frequently asked questions
North India Pharma is an active private limited company based in Delhi, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 08 January 2014 (12+ years old) and is registered under CIN U52100DL2014PTC263184.
North India Pharma has 2 current directors:
- Mudit Doshi - Additional Director
- Paras Doshi - Director
The latest financial statements of North India Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of North India Pharma is 07AAECN6438N1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of North India Pharma is U52100DL2014PTC263184. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
North India Pharma has 3 court cases on record: 1 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.
North India Pharma was incorporated on 08 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of North India Pharma by revenue are Fox Tradelinks Private Limited, Million Technocoats Private Limited, Empiai Pharmaceuticals Private Limited, I Ox Industries Private Limited, Wallgrip India Private Limited, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Shailen Doshi ceased to be Director on 31 May 2024. Mudit Doshi was appointed as Additional Director on 30 May 2024. Paras Doshi was appointed as Director on 08 Jan 2014.
Yes, North India Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0033929).
The registered office of North India Pharma is at G – 42 Ground Floor, Vardhman Fashion Mall Pitampura, Delhi, India – 110034.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages